Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry.

导出 LinkOut

翻译打印收藏纠错

作者： Martin J,Bergman ^[1] ; Patrick,Zueger ^[2] ; Jayeshkumar,Patel ^[2] ; Christopher D,Saffore ^[3] ; Ia,Topuria ^[4] ; Cristi,Cavanaugh ^[4] ; Siran,Fang ^[2] ; Jerry,Clewell ^[2] ; Alexis,Ogdie ^[5]

作者单位： College of Medicine, Drexel University, Philadelphia, PA, USA. ^[1] AbbVie Inc., North Chicago, IL, USA. ^[2] AbbVie Inc., North Chicago, IL, USA. christopher.saffore@abbvie.com. ^[3] OM1, Inc., Boston, MA, USA. ^[4] University of Pennsylvania, Philadelphia, PA, USA. ^[5]

关键词 Administrative claims Ankylosing spondylitis Disease control Disease registry Economic burden Healthcare resource utilization Psoriatic arthritis

DOI 10.1007/s40744-022-00504-2

PMID 36333490

发布时间 2023-09-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Rheumatology and therapy

2023年10卷1期

187-199页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry.

Rheumatology and therapy

相似文献

Rheumatology and therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry.

Rheumatology and therapy

相似文献

Rheumatology and therapy

相关期刊

检索历史清除